Premium
Loss of polarity and De novo expression of the β 1 family of integrins in thyroid tumors
Author(s) -
Vitale Mario,
Bassi Vincenzo,
Illario Maddalena,
Fenzi Gianfranco,
Casamassima Adele,
Rossi Guido
Publication year - 1994
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.2910590208
Subject(s) - integrin , thyroid , cancer research , medicine , biology , pathology , endocrinology , receptor
The expression and cell‐membrane distribution of the β 1 family of integrins (very‐late‐activation antigens, VLA) were investigated in benign and malignant human thyroid tumors. We compared tissue samples of normal glands, nodular goiters, adenomas and carcinomas. We also examined 3 thyroidcarcinoma cell lines cultured in vitro. The expression of subunits of the β 1 family of integrins was assessed by flow cytometry and specific antibodies in dispersed single‐cell suspensions and by immunofluorescence on frozen tissue sections. In contrast to the heterogeneity of the expression of β 1 integrins observed in other tumors, thyroid neoplastic lesions showed a remarkably constant VLA profile. In all tumors, benign as well as malignant, and in carcinoma cell lines, all sub‐units of β 1 integrins were expressed at high levels. While sub‐units α 1 , α 3 , α 5 , α 6 and occasionally α 2 were also present in a cell sub‐set of normal glands and nodular goiters, expression of α 4 was restricted to neoplastic lesions; this integrin can be therefore considered an antigen associated with thyroid tumors. It has been reported that in normal glands and in nodular goiters, the expression of β 1 integrins is restricted to the basal‐cell membrane. Immunofluorescence on tissue sections showed instead that, in adenomas and carcinomas, the polarized distribution of these integrins on the cell membrane is lost.